# US 2024/0197807 A1 · Water soluble formulations containing coenzyme-q10 and ashwagandha root extract

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197807 A1
- Document ID: US20240197807A1
- Status: Published application
- Kind: A1
- Application number: 18/553,328
- Filed: 2022-09-30
- Published: 2024-06-20
- Earliest claimed: 2021-03-30
- Applicants: Next Remedies Inc.
- Inventors: Siyaram PANDEY; Caleb VEGH
- Web page: https://patentgrep.com/patent/US20240197807A1

## CPC

- A61K 36/81: Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present application relates to water-soluble formulations. More specifically, the present application relates to formulations comprising at least one of Coenzyme-Q10 and an ashwagandha root extract and a solubilizing agent. More specifically, the present application relates to formulations comprising water-solubilized Coenzyme-Q10 in combination with alcohol-extracted ashwagandha root extract; water-solubilized alcohol-extracted ashwagandha root extract; or water-solubilized Coenzyme-Q10 in combination with water-solubilized alcohol-extracted ashwagandha root extract. The formulations of the present application are useful for treating reducing or preventing a neurological diseases or disorders.

## Claims

### Claim 1

A formulation comprising:
(i) Coenzyme-Q10 water-solubilized with at least one solubilizing agent of Formula (I):
wherein
X is a residue of a hydrophobic moiety selected from sterols, tocopherols and derivatives thereof;
Y is a residue of a hydrophilic moiety selected from polyalcohols, polyethers and derivatives thereof;
m is 0 or 1;
n is an integer of from 0 to 18;
p is 1 or 2; and
q is 1 or 2; and
(ii) an alcohol-extracted ashwagandha root extract.

### Claim 2

A formulation comprising:
(i) an alcohol-extracted ashwagandha root extract water-solubilized with at least one solubilizing agent of Formula (I):
wherein
X is a residue of a hydrophobic moiety selected from sterols, tocopherols and derivatives thereof;
Y is a residue of a hydrophilic moiety selected from polyalcohols, polyethers and derivatives thereof;
m is 0 or 1;
n is an integer of from 0 to 18;
p is 1 or 2; and
q is 1 or 2.

### Claim 3

A formulation comprising:
(i) Coenzyme-Q10 water-solubilized with at least one solubilizing agent of Formula (I):
wherein
X is a residue of a hydrophobic moiety selected from sterols, tocopherols and derivatives thereof;
Y is a residue of a hydrophilic moiety selected from polyalcohols, polyethers and derivatives thereof;
m is 0 or 1;
n is an integer of from 0 to 18;
p is 1 or 2; and
q is 1 or 2; and
(ii) an alcohol-extracted ashwagandha root extract water-solubilized with at least one solubilizing agent of Formula (I).

### Claim 4 (depends on 1)

The formulation of claim 1, wherein the hydrophobic moiety in Formula (I) is selected from cholesterol, 7-dehydrocholesterol, campesterol, sitosterol, ergosterol, stigmasterol, α-tocopherol, β-tocopherol, γ-tocopherol and δ-tocopherol.

### Claim 5 (depends on 1)

The formulation of claim 1, wherein the hydrophobic moiety is α-tocopherol.

### Claim 6 (depends on 1)

The formulation of claim 1, wherein the hydrophilic moiety in Formula (I) is a polyether.

### Claim 7 (depends on 6)

The formulation of claim 6, wherein the polyether is a polyalkylene glycol.

### Claim 8

(canceled)

### Claim 9 (depends on 8)

The formulation of claim 8, wherein the polyethylene glycol has an average molecular weight of from about 300 to about 5000, or about 400 to about 1000.

### Claim 10 (depends on 1)

The formulation of claim 1, wherein the hydrophilic moiety in Formula (I) is a polyalcohol.

### Claim 11 (depends on 1)

The formulation of claim 1, wherein when p, m and q are all equal to 1 and the hydrophobic moiety is cholesterol, n is greater than 4 and not equal to 8.

### Claim 12 (depends on 1)

The formulation of claim 1, wherein when p, m and q are all equal to 1 and the hydrophobic moiety is α-(+)-tocopherol, n is not equal to 2.

### Claim 13 (depends on 1)

The formulation of claim 1, wherein n is an integer of from 2 to 10, or 6 to 10, or 8.

### Claim 14 (depends on 1)

The formulation of claim 1, wherein the at least one compound of Formula (I) is polyoxyethanyl-α-tocopheryl sebacate (PTS) monomer, PTS dimer or combinations thereof.

### Claim 15 (depends on 14)

The formulation of claim 14, wherein the at least one compound of Formula (I) is PTS monomer.

### Claim 16 (depends on 14)

The formulation of claim 14, wherein the at least one compound of Formula (I) is PTS dimer.

### Claim 17 (depends on 14)

The formulation of claim 14, wherein the at least one compound of Formula (I) is a combination of PTS monomer and PTS dimer.

### Claim 18 (depends on 1)

The formulation of claim 1, wherein the ratio of the solubilizing agent to the Coenzyme-Q10 (w/w) is from about 2:1 to about 12:1 or about 2:1 to 5:1, or about 2:1 or about 3:1.

### Claim 19 (depends on 1)

The formulation of claim 1, wherein the ratio of the solubilizing agent to the the alcohol-extracted ashwagandha root extract (w/w) is from about 10:1 to about 1:1, or from about 5:1 to 2:1, or about 3:1 or about 2.8:1.

### Claim 20 (depends on 1)

The formulation of claim 1, wherein the formulation contains from about 0.1 mg/mL to about 100 mg/ml of the water solubilized Coenzyme-Q10, or from about 0.1 mg/ml to about 300 mg/ml of the ashwagandha root extract, or from about 0.1 mg/mL to about 20 mg/ml of the water solubilized ashwagandha root extract.

### Claim 21 (depends on 1)

The formulation of claim 1, wherein the alcohol-extracted ashwagandha root extract is ethanol-extracted ashwagandha root extract.

### Claim at position 22

-28. (canceled)
